Position in INDV
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$408,827
New position
Shares Held
13,413
first reported quarter
Ownership
0.011%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Marex Group plc holds $32,136,552 across 11 Drug Manufacturers - Specialty & Generic names. INDV ranks #6 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HIMS |
Hims & Hers Health, Inc.
|
1,338,814 | $27,793,778 | |
| 2 | RGC |
Regencell Bioscience Holdings Ltd
|
31,600 | $803,588 | |
| 3 | ALKS |
Alkermes plc.
|
19,891 | $703,345 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
22,529 | $678,573 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
4,920 | $648,160 | |
| 6 | INDV |
Indivior Pharmaceuticals, Inc.
This page
|
13,413 | $408,827 | |
| 7 | BHC |
Bausch Health Companies Inc.
|
74,772 | $403,768 | |
| 8 | VTRS |
Viatris Inc
|
25,594 | $345,774 |
All Filings in INDV
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $408,827 | 13,413 | Shares | Defined | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||